Michelle Primeau1,2, Anda Gershon2, Lisa Talbot3, Isabelle Cotto2, Linda Lotspeich2, Antonio Hardan2,4, Joachim Hallmayer2,4, Ruth O'Hara2,3,5. 1. Palo Alto Medical Foundation, Department of Sleep Medicine, Sunnyvale, CA. 2. Stanford University Department of Psychiatry and Behavioral Sciences, Stanford, CA. 3. San Francisco VA Medical Center, San Francisco, CA. 4. Stanford University Department of Psychiatry and Behavioral Sciences, Child and Adolescent Psychiatry, Stanford, CA. 5. Mental Illness Research, Education, and Clinical Center (MIRECC): VISN 21: Sierra Pacific Network, Department of Veterans Affairs, Palo Alto, CA.
Abstract
STUDY OBJECTIVES: Polysomnography (PSG) is the gold standard for the assessment of sleep, yet the extensive apparatus required for monitoring with PSG can be difficult to tolerate, particularly in children. Clinical populations, such as those with anxiety or tactile sensitivity, may have even greater difficulty tolerating the PSG equipment. This study evaluated an innovative protocol for obtaining full PSG in individuals diagnosed autism spectrum disorders (ASD) or developmental delay (DD), as well as typically developing controls (TD). The primary aim was to assess whether this protocol was equally successful for obtaining PSG between these groups. METHODS: One hundred sixty-one individuals were recruited for participation; 93 with a diagnosis of ASD, 23 with a diagnosis of DD, and 45 TD. The participants and families were instructed on a procedure of systematic desensitization to the ambulatory PSG equipment; PSG was performed in the home of the participant. RESULTS: PSG was successfully attained in 144 (89.4%) participants. There was no difference in completion rate by diagnosis (p = 0.1), though younger age (p = 0.018) and duration of desensitization (p = 0.024) did predict PSG failure. Further, it was found that individuals with ASD took longer to desensitize to the equipment (16.08 d), than those with DD (8.04 d) or TD (0.98 d). CONCLUSIONS: Systematic desensitization to PSG equipment, in combination with PSG completed in the home, allows for individuals with ASD to be equally successful in completing PSG, though they do take longer to acclimate to the equipment.
STUDY OBJECTIVES: Polysomnography (PSG) is the gold standard for the assessment of sleep, yet the extensive apparatus required for monitoring with PSG can be difficult to tolerate, particularly in children. Clinical populations, such as those with anxiety or tactile sensitivity, may have even greater difficulty tolerating the PSG equipment. This study evaluated an innovative protocol for obtaining full PSG in individuals diagnosed autism spectrum disorders (ASD) or developmental delay (DD), as well as typically developing controls (TD). The primary aim was to assess whether this protocol was equally successful for obtaining PSG between these groups. METHODS: One hundred sixty-one individuals were recruited for participation; 93 with a diagnosis of ASD, 23 with a diagnosis of DD, and 45 TD. The participants and families were instructed on a procedure of systematic desensitization to the ambulatory PSG equipment; PSG was performed in the home of the participant. RESULTS: PSG was successfully attained in 144 (89.4%) participants. There was no difference in completion rate by diagnosis (p = 0.1), though younger age (p = 0.018) and duration of desensitization (p = 0.024) did predict PSG failure. Further, it was found that individuals with ASD took longer to desensitize to the equipment (16.08 d), than those with DD (8.04 d) or TD (0.98 d). CONCLUSIONS: Systematic desensitization to PSG equipment, in combination with PSG completed in the home, allows for individuals with ASD to be equally successful in completing PSG, though they do take longer to acclimate to the equipment.
Authors: Carole L Marcus; Joel Traylor; Sarah N Biggs; Robin S Roberts; Gillian M Nixon; Indra Narang; Rakesh Bhattacharjee; Margot J Davey; Rosemary S C Horne; Maureen Cheshire; K Jeremy Gibbons; Joanne Dix; Elizabeth Asztalos; Lex W Doyle; Gillian F Opie; Judy D'ilario; Lorrie Costantini; Ruth Bradford; Barbara Schmidt Journal: J Clin Sleep Med Date: 2014-08-15 Impact factor: 4.062
Authors: Shubhadeep Das; Jodi Mindell; Genevieve C Millet; Dafna Ofer; Suzanne E Beck; Thornton B A Mason; Lee J Brooks; Joel Traylor; Carole L Marcus Journal: J Clin Sleep Med Date: 2011-02-15 Impact factor: 4.062
Authors: R Nisha Aurora; Rochelle S Zak; Anoop Karippot; Carin I Lamm; Timothy I Morgenthaler; Sanford H Auerbach; Sabin R Bista; Kenneth R Casey; Susmita Chowdhuri; David A Kristo; Kannan Ramar Journal: Sleep Date: 2011-03-01 Impact factor: 5.849
Authors: Richard B Berry; Rohit Budhiraja; Daniel J Gottlieb; David Gozal; Conrad Iber; Vishesh K Kapur; Carole L Marcus; Reena Mehra; Sairam Parthasarathy; Stuart F Quan; Susan Redline; Kingman P Strohl; Sally L Davidson Ward; Michelle M Tangredi Journal: J Clin Sleep Med Date: 2012-10-15 Impact factor: 4.062
Authors: R Nisha Aurora; Carin I Lamm; Rochelle S Zak; David A Kristo; Sabin R Bista; James A Rowley; Kenneth R Casey Journal: Sleep Date: 2012-11-01 Impact factor: 5.849
Authors: Innessa Donskoy; Darius Loghmanee; Barry G Fields; Matthew Troester; William Martin Journal: J Clin Sleep Med Date: 2022-01-01 Impact factor: 4.062
Authors: Christina F Chick; Anisha Singh; Lauren A Anker; Casey Buck; Makoto Kawai; Christine Gould; Isabelle Cotto; Logan Schneider; Omer Linkovski; Rosy Karna; Sophia Pirog; Kai Parker-Fong; Christian R Nolan; Deanna N Shinsky; Priyanka N Hiteshi; Oscar Leyva; Brenda Flores; Ryan Matlow; Travis Bradley; Josh Jordan; Victor Carrion; Ruth O'Hara Journal: J Clin Sleep Med Date: 2022-09-01 Impact factor: 4.324